pC014 - LwCas13a-msfGFP Citations (11)
Originally described in: RNA targeting with CRISPR-Cas13.Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, Verdine V, Cox DBT, Kellner MJ, Regev A, Lander ES, Voytas DF, Ting AY, Zhang F Nature. 2017 Oct 4. doi: 10.1038/nature24049. PubMed Journal
Articles Citing pC014 - LwCas13a-msfGFP
| Articles |
|---|
| CRISPR-Cas13d mediates robust RNA virus interference in plants. Mahas A, Aman R, Mahfouz M. Genome Biol. 2019 Dec 2;20(1):263. doi: 10.1186/s13059-019-1881-2. PubMed |
| Effective RNA Knockdown Using CRISPR-Cas13a and Molecular Targeting of the EML4-ALK Transcript in H3122 Lung Cancer Cells. Saifullah, Sakari M, Suzuki T, Yano S, Tsukahara T. Int J Mol Sci. 2020 Nov 24;21(23). pii: ijms21238904. doi: 10.3390/ijms21238904. PubMed |
| Acetyl-CoA synthases are essential for maintaining histone acetylation under metabolic stress during zygotic genome activation in pigs. Zhou W, Nie ZW, Zhou DJ, Cui XS. J Cell Physiol. 2021 Oct;236(10):6948-6962. doi: 10.1002/jcp.30355. Epub 2021 Mar 8. PubMed |
| The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons. Wu QW, Kapfhammer JP. Toxins (Basel). 2021 Apr 7;13(4). pii: toxins13040262. doi: 10.3390/toxins13040262. PubMed |
| In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells. Challagulla A, Schat KA, Doran TJ. Methods Protoc. 2021 Jun 8;4(2). pii: mps4020040. doi: 10.3390/mps4020040. PubMed |
A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins.
Gama-Brambila RA, Chen J, Dabiri Y, Tascher G, Nemec V, Munch C, Song G, Knapp S, Cheng X.
JACS Au. 2021 May 12;1(6):777-785. doi: 10.1021/jacsau.1c00007. eCollection 2021 Jun 28.
PubMed
Associated Plasmids |
| Nosema bombycis microRNA-like RNA 8 (Nb-milR8) Increases Fungal Pathogenicity by Modulating BmPEX16 Gene Expression in Its Host, Bombyx mori. Dong Z, Zheng N, Hu C, Deng B, Fang W, Wu Q, Chen P, Huang X, Gao N, Lu C, Pan M. Microbiol Spectr. 2021 Oct 31;9(2):e0104821. doi: 10.1128/Spectrum.01048-21. Epub 2021 Oct 27. PubMed |
| PERSIST platform provides programmable RNA regulation using CRISPR endoRNases. DiAndreth B, Wauford N, Hu E, Palacios S, Weiss R. Nat Commun. 2022 May 11;13(1):2582. doi: 10.1038/s41467-022-30172-3. PubMed |
| CRISPR-Cas13-Mediated Knockdown of Regulator of G-Protein Signaling 8 (RGS8) Does Not Affect Purkinje Cell Dendritic Development. Wu QW, Kapfhammer JP. Front Cell Dev Biol. 2022 May 31;10:854273. doi: 10.3389/fcell.2022.854273. eCollection 2022. PubMed |
| Hierarchically tumor-activated nanoCRISPR-Cas13a facilitates efficient microRNA disruption for multi-pathway-mediated tumor suppression. Liu X, Yang S, Wang L, Wu X, Wang X, Ou C, Yang J, Song L, Zhou S, Wu Q, Gong C. Theranostics. 2023 May 8;13(9):2774-2786. doi: 10.7150/thno.81776. eCollection 2023. PubMed |
| Transcript-specific induction of stop codon readthrough using a CRISPR-dCas13 system. Manjunath LE, Singh A, Devi Kumar S, Vasu K, Kar D, Sellamuthu K, Eswarappa SM. EMBO Rep. 2024 Apr;25(4):2118-2143. doi: 10.1038/s44319-024-00115-8. Epub 2024 Mar 18. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.